A COVID-19 vaccine developed by the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) is headed for human clinical trials. Health Canada approved VIDO's vaccine for the trials last week. The Pfizer-BioNTech vaccine, which is currently being used in Saskatchewan, needs to be stored in ultra-low temperature freezers at -70 C.The Saskatchewan government said 1,786 doses of the Pfizer-BioNTech vaccine had been administered to health-care workers in the province as of Dec. 23. If all goes well with the human clinical trials, VIDO's vaccine could be ready for public use by late 2021. VIDO said it's also in the process of developing a second COVID-19 vaccine.

Source: CBC News December 29, 2020 17:48 UTC